Aaronson NL, et al. – Authors performed a systematic review of the literature to assess cost effectiveness of transoral robotic surgery for the treatment of oropharyngeal squamous cell carcinoma. Findings suggested transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC) as cost–effective compared to other available modalities due to decreased hospital stay, increased chance of finding an unknown primary and thereby avoiding some adjuvant treatment, and decreased rates of gastrostomy tube and tracheotomy. Further studies were suggested to define and measure costs and compare TORS with open surgery and non–surgical treatments.